GREATER CERTAINTY IN DRUG DEVELOPMENT
Certainty by Certara offers exclusive access to industry leaders and clinical researchers with opportunities to achieve better certainty in drug development through the presentations related to Model-informed Drug Development, clinical pharmacology, QSP, PBPK, and more.
You can learn case studies and the latest scientific trends from our special guest speakers and Certara’s experts and ask questions directly. We hope this annual event will help you connect with innovative researchers from various pharmaceutical companies and bring the innovations to your team.
- Location: Shinagawa, Tokyo
- Venue: TKP Garden City PREMIUM Shinagawa Takanawa
- Time: 10am – 4pm
- Registration fee: Free of charge
Featured topics by Certara
Download agenda and details of CERTAINTY Japan
- FDA project Optimus and MIDD Case Studies: Road to Approval and Beyond
by Mayumi Hasegawa, PhD, Sr Director, Certara Drug Development Solutions - How PBPK help accelerate your drug development – Case studies
by Noriko Okudaira, PhD, Sr Director of PBPK Consultancy, Simcyp - Moving from Hype to Reality in Pharmaceutical AI Applications
by Sean McGee, Director of Product, Certara - Biosimulation at scale: Industrializing quantitative systems pharmacology to guide drug-development decision making
by John M. Burke, PhD, VP, Global Head of ABM Scientific Affairs, Certara - Forms, Data, Docs: How Certara Cloud Optimizes Trials Towards Submission Readiness
by Philip Johnston, Vice President, Product, Certara - The Era of Generative AI: Revolutionizing the Regulatory writing
by Rico Fujita, Solution Consultant, Certara
Guest Speakers
Download details of speakers’ bio and session information
- Shintaro Nakayama, PhD, Daiichi Sankyo
- Kenji Shimuzu, Nobelpharma
- Shinji Kobuchi PhD, Kyoto Pharmaceutical University
- Tak Yamada, NVIDIA
